Bliss GVS Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE416D01022
  • NSEID: BLISSGVS
  • BSEID: 506197
INR
737.60
28.3 (3.99%)
BSENSE

Sep 28, 04:01 PM

BSE+NSE Vol: 30.64 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Innova Captab
Bliss GVS Pharma
Aarti Pharma
Morepen Labs.
SPARC
Orchid Pharma
Supriya Lifesci.
Sanofi India
Sanofi Consumer
P & G Health Ltd
Symbiotec Pharma

Why is Bliss GVS Pharma Ltd ?

1
The company is Net-Debt Free
2
With a growth in Net Sales of 37.65%, the company declared Very Positive results in Jan 70
3
Increasing Participation by Institutional Investors
  • Institutional investors have increased their stake by 2.05% over the previous quarter and collectively hold 17.54% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Returns over the last 3 years
  • Along with generating 408.34% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Bliss GVS Pharma should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Bliss GVS Pharma for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Bliss GVS Pharma
408.34%
6.71
60.89%
Sensex
-9.52%
-0.70
13.59%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
10.30%
EBIT Growth (5y)
9.42%
EBIT to Interest (avg)
15.70
Debt to EBITDA (avg)
0.68
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.74
Tax Ratio
29.82%
Dividend Payout Ratio
4.10%
Pledged Shares
0
Institutional Holding
17.54%
ROCE (avg)
12.39%
ROE (avg)
9.73%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
55
Industry P/E
38
Price to Book Value
6.32
EV to EBIT
45.10
EV to EBITDA
37.12
EV to Capital Employed
7.06
EV to Sales
7.35
PEG Ratio
1.96
Dividend Yield
0.21%
ROCE (Latest)
12.48%
ROE (Latest)
10.95%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Loading Valuation Snapshot...
Footer loading